Anaergia Announces Further Delay in the Filing of Audited Financial Statements and Related Disclosures

Author's Avatar
Mar 31, 2023

Anaergia Inc. (“Anaergia” or the “Company”) (TSX: ANRG) announced today that it will further delay filing its annual information form for the year ended December 31, 2022, audited annual consolidated financial statements for the year ended December 31, 2022, the related management’s discussion and analysis of financial condition and results of operations and CEO and CFO certificates relating to the audited annual financial statements as required by National Instrument 52-109 – Certificate of Disclosure in Issuers’ Annual and Interim Filings (collectively, the “Required Documents”) beyond the March 31, 2023 deadline.